Information for the public

Fulvestrant (Faslodex) is not normally available on the NHS for postmenopausal women who have locally advanced or metastatic breast cancer that:

  • is oestrogen-receptor positive and
  • has not been treated with endocrine therapy before.

Your doctor should talk with you about other treatment options. If you are already taking it, you should be able to continue until you and your doctor decide when best to stop.

Information and support

NHS Choices may be a good place to find out more.

You can also get support from your local Healthwatch.

NICE is not responsible for the quality or accuracy of any information or advice provided by these organisations.

ISBN: 978-1-4731-2807-1


This page was last updated: 31 January 2018